BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » interview » Page 4

L7 Informatics, Data Management and Process Automation Solutions for Cell and Gene Therapy Companies

April 22, 2019 By Cade Hildreth (CEO) Leave a Comment

L7 Informatics

L7 InformaticsHeadquartered in Austin, Texas, L7 Informatics, provides software and services that enable synchronized solutions for cell and gene therapy companies. Specifically, L7’s novel Enterprise Science Platform (ESP) is a scientific process and data management (SPDM) solution that enables life science and healthcare companies to connect people, processes, and systems. The company’s mission is to use this technology to accelerate discoveries and drive precision healthcare.

In this interview, Vasu Rangadass – President and CEO of L7 Informatics – and I explore the company’s origins, its unique ESP technology, future directions, and more. Enjoy! [Read more…]

Filed Under: Interviews Tagged With: interview, L7 Informatics

Pluristem Therapeutics, Interview with Yaky Yanay, President and Co-CEO

March 28, 2019 By Cade Hildreth (CEO) 1 Comment

Placental cell therapies

Pluristem TherapeuticsPluristem Therapeutics (PSTI) is a clinical-stage company that is a proprietary 3D manufacturing technology to develop placental cell therapies for conditions that include ischemia, muscle injury, and exposure to radiation. I had the honor of interviewing Mr. Yaky Yanay, President and Co-CEO of Pluristem Therapeutics.

In this interview, we discuss the history of Pluristem Therapeutics, its clinical-stage products, intellectual property (IP) portfolio, marketing strategy and future directions.

Enjoy these insights into Pluristem Therapeutics, a world-class leader in cell therapy manufacturing and placental-derived products. [Read more…]

Filed Under: Interviews, MSCs Tagged With: clinical trial, interview, placental, Pluristem

TBL Performance Plastics, Fully-Integrated Manufacturing Capabilities for Life Science Markets

November 15, 2018 By Cade Hildreth (CEO) Leave a Comment

TBL aSURE Fitting

TBL Performance PlasticsTBL Performance Plastics (TBL) is a privately-owned company with over 50 years of experience in plastics and related life science industries. I became interested in the company, because it offers fully-integrated manufacturing capabilities that could support the explosive growth of the cell and gene therapy (CGT) industry, where there is an ever expanding need for manufacturing equipment to support the production of innovative products.

TBL fills this role by providing tailored solutions to companies from across the life science spectrum.  At its facility in Sparta, New Jersey, TBL operates ISO Class 7 cleanrooms for fabrication and packaging, follows cGMP’s, and specializes in tubing, fittings, and connective technologies for an endless array of fluid-transfer processes.  [Read more…]

Filed Under: Cell Therapy Tagged With: interview

ORIG3N, Producing Patient-Specific iPS Cells – Interview with Robin Smith, CEO

November 12, 2018 By Cade Hildreth (CEO) Leave a Comment

ORIG3N

ORIG3N ORIG3N, a biotechnology start-up headquartered in Boston, is attracting global attention for several reasons. First, it has created the world’s largest blood cell repository. ORIG3N is using these blood cells to produce patient-specific induced pluripotent stem cells (iPSCs), allowing the cells to be ever-renewing and giving rise to a living database of humanity known as LifeCapsule.

Second, the company has two other business segments, called LifeProfile and LifeSystems. These business units of ORIG3N help people to better understand the links between their genes and how their minds and bodies work.

Third, ORIG3N has identified HLA Superdonor matches for 90% of the U.S. population, positioning it to be custodians of this “first of a kind asset on planet earth.”

[Read more…]

Filed Under: Interviews, iPS Cells Tagged With: genetic testing, interview, iPSC, news, Orig3n

Interview with Dr. Desirée Cox, CEO of the HEALinc Future Health Innovation Summit

September 6, 2018 By Cade Hildreth (CEO) Leave a Comment

Desiree Cox
Desiree Cox, MD, PhD

Dr. Desirée Cox, MD, PhD is a thought leader in future health innovation. She is a Rhodes Scholar, medical doctor, published author and contemporary visual artist whose work has been shown in exhibitions all over the world. She is also the founder and CEO of The HEALinc Innovation Incubator and the HEALinc Future Health Innovation Summit.

The 2018 Inaugural Summit takes place this year, October 7th-9th at the Melia Hotel in Nassau, Bahamas.

Dr. Cox has earned degrees from McGill University (Canada), Oxford University (UK) and Cambridge University (UK). She is an honorary professor of the Rutgers Graduate School of Biomedical Sciences and a former university professor and honorary professor of creativity, health and wellbeing at the University of Exeter (UK). She has also been recognized by the British Medical Journal as a ‘Renaissance Woman’ for her application of psychological medicine to real world problems. [Read more…]

Filed Under: Interviews Tagged With: conference, interview

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.